GTF2E2 (General Transcription Factor IIE Subunit 2) is a 33 kDa protein involved in RNA polymerase II-mediated transcription initiation. Antibodies targeting GTF2E2 are primarily research tools for studying transcriptional regulation.
Potential Misinterpretation: TBR2/Eomes Antibody
If "GTE2" refers to a typographical error for TBR2/Eomes (T-box brain protein 2), this antibody targets a transcription factor critical for cortical neurogenesis and immune cell differentiation.
Comparative Analysis of Antibody Performance
Antibody
Applications
Species Reactivity
Key Validation Data
Source
Anti-GTF2E2
IP, ChIP, WB
Human
Band at 33 kDa in Jurkat cells
Anti-TBR2/Eomes
IHC, WB
Human, Mouse
Bands at 72-85 kDa; cortical progenitor staining
Critical Considerations
Nomenclature Accuracy: The absence of "GTE2" in antibody databases (e.g., Antibody Society listings) suggests a possible typographical error. Researchers should verify gene symbols (e.g., GTF2E2 vs. EOMES).
Functional Context:
GTF2E2 antibodies are used in transcriptional studies (e.g., RNA Pol II interactions).
TBR2/Eomes antibodies are pivotal in neurodevelopmental and immunological research.
Recommendations for Use
For transcriptional regulation studies, validate GTF2E2 antibodies with recombinant protein controls (e.g., ab228581).
For neurodevelopmental research, confirm TBR2/Eomes specificity using knockout tissue controls.